To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
11 Current news of Uni Würzburg
rss
2013 Louis-Jeantet Prize for Medicine
29-01-2013
The 2013 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the geneticist, Michael Stratton, director of the Wellcome Trust Sanger Institute, and jointly to the German biochemists Peter Hegemann, researcher at the Department of Experimental Biophysics at the Humboldt University, and Georg Nagel, ...
Silicone Breast Implants with Spider Silk-Based Coating Show Reduced Side-Effects in Preclinical Studies
03-12-2012
AMSilk is developing a novel spider silk-based coating, called BioShield-S1, for silicone breast implants designed to reduce commonly known side effects that are initiated when the immune system reacts to the implants. Preclinical tests conducted jointly with the University of Bayreuth, ...
New Agent against Tropical Parasites
19-07-2012
There is an urgent need for better drugs to treat African sleeping sickness. Würzburg scientists have developed a very promising new agent, which is now to be further optimized. African sleeping sickness is caused by the tropical parasite Trypanosoma brucei. This unicellular, worm-shaped ...
Living cells made to fluoresce
13-08-2010
Individual molecules and their dynamics can also be made visible in living cells using conventional fluorophores at a resolution of around 20 nanometers. How this is done is being revealed for the first time by researchers from Würzburg, Bielefeld, and New York in the journal Nature ...
Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
26-04-2010
Studies led by Stony Brook University professor of chemistry Peter J. Tonge indicate that modifications that enhance the time a drug remains bound to its target, or residence time, may lead to better diagnostic and therapeutic agents. Tonge presented these results at the American Society for ...
Multiple sclerosis: T cells as serial killers
16-10-2009
In multiple sclerosis, the immune system also damages the nerve cells with its misguided activities. This is what regularly happens in the targeted immunological attack on the myelin sheaths of the nerve cells, as shown experimentally for the first time by researchers from Würzburg and ...
Together they make you ill
27-07-2009
There are still gaps in our knowledge about the origin and course of complex diseases like multiple sclerosis. Now, researchers of the University of Würzburg have studied the interaction between two important factors - with a clear result. Chronic inflammatory diseases of the central nervous ...
Multiple Sclerosis: Benefactors in the Brain
13-07-2009
The inflammatory process in the brain of multiple sclerosis patients is triggered by their own immune system. However, there is one type of immune cells that seems to fight against the destructive progress - and might be used for therapeutic purposes in future. These "beneficial" immune ...
Inducible Gene Silencing in Transgenic Rats via RNAi
25-11-2008
TaconicArtemis GmbH, a subsidiary of Taconic, announced the publication of a scientific breakthrough achieved in a collaboration with the Universities Goettingen and Wuerzburg (Germany). For the first time it is now possible to inactivate disease-related genes in an inducible and reversible ...
Kiadis Pharma announces collaboration with the Julius Maximilians University of Würzburg, Germany
02-06-2008
Kiadis Pharma announced the clinical development collaboration for its lead product ATIR(TM) with Dr. Stephan Mielke and Professor Dr. Hermann Einsele from the Allogeneic Stem Cell Transplant Center, Division of Hematology and Oncology, Department of Internal Medicine II at the ...
Netmeeting
